Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients

BACKGROUND: Taurolidin/Citrate (TauroLock™), a lock solution with broad spectrum antimicrobial activity, may prevent bloodstream infection (BSI) due to coagulase-negative staphylococci (CoNS or 'MRSE' in case of methicillin-resistant isolates) in pediatric cancer patients with a long term...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, Arne, Ammann, Roland A, Wiszniewsky, Gertrud, Bode, Udo, Fleischhack, Gudrun, Besuden, Mette M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515312/
https://www.ncbi.nlm.nih.gov/pubmed/18664278
http://dx.doi.org/10.1186/1471-2334-8-102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515312/
https://www.ncbi.nlm.nih.gov/pubmed/18664278
http://dx.doi.org/10.1186/1471-2334-8-102

Ejemplares similares